APP and Alzheimer disease: These findings suggest that decreased LMTK1 expression in Alzheimer’s disease could contribute to amyloidogenic cleavage of APP and amyloid beta accumulation by perturbing APP endosomal trafficking which in turn can induce further transport and synaptic damages.